6-三甲基硅烷基氨基-己酸三甲基硅烷基酯 | 18159-76-7

• 分子结构分类: 有机化合物 - 有机金属化合物 - 有机类金属化合物
• 中文名称: 6-三甲基硅烷基氨基-己酸三甲基硅烷基酯
• 中文别名: 己酸,6-[(三甲基甲硅烷基)氨基]-,三甲基甲硅烷基酯
• 英文名称: 6-trimethylsilanylamino-hexanoic acid trimethylsilanyl ester
• 英文别名: 6-Trimethylsilylamino-hexansaeure-trimethylsilylester；Hexanoic acid, 6-amino-, bis(trimethylsilyl) deriv.；trimethylsilyl 6-(trimethylsilylamino)hexanoate
• CAS: 18159-76-7
• 化学式: C₁₂H₂₉NO₂Si₂
• 分子量: 275.539
• InChiKey: ZCKNYMWEAAHMPL-UHFFFAOYSA-N

物化性质

• 沸点：
  114 °C(Press: 2.5 Torr)
• 密度：
  0.8925 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  3.35
• 重原子数：
  17
• 可旋转键数：
  9
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.92
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  6-三甲基硅烷基氨基-己酸三甲基硅烷基酯 在 sodium carbonate 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 生成 6-苯甲酰基氨基-己酸
  参考文献：
  名称：

  Studies Directed at the Use of a Parallel Synthesis Matrix to Increase Throughput in an in Vivo Assay

  摘要：

  Heparin is the anticoagulant of choice for hospitalized patients, but it is dosed only by injection because it is not absorbed following oral administration. We have discovered and prepared compounds (delivery agents) that facilitate the gastrointestinal absorption of heparin in rats, monkeys, and humans when given orally. We are currently developing a parallel synthesis approach to increase our delivery agent screening throughput in vivo. This approach has been used to produce micromolar quantities of compounds for testing in rats in a 5 x 5 parallel synthesis array. Using an amine benzoylation reaction sequence, 10 mixtures were prepared. These mixtures contained equal weight quantities of five N-substituted, non-alpha, amino acid delivery agents. Each of these mixtures was orally administered to rats in combination with heparin, and plasma clotting times (APTT) were measured to determine activity. Deconvolution of the data accurately identified the most active individual components. Independent synthesis of these compounds verified their activity. This parallel synthesis approach is an effective tool for the screening of oral heparin delivery agents and has increased screening throughput significantly.

  DOI：

  10.1021/jm990416r
• 作为产物：
  描述：

  trimethyl(butyl-amino)silane 、 6-氨基己酸 生成 6-三甲基硅烷基氨基-己酸三甲基硅烷基酯
  参考文献：
  名称：

  Ruehlmann, Journal fur praktische Chemie (Leipzig 1954), 1959, vol. <4>9, p. 86,89,90,315,320

  摘要：

  DOI：

文献信息

• A Versatile Solid-Phase Approach to the Synthesis of Oligonucleotide Conjugates with Biodegradable Hydrazone Linker
  作者：Mariya I. Meschaninova、Nina S. Entelis、Elena L. Chernolovskaya、Alya G. Venyaminova

  DOI：10.3390/molecules26082119

  日期：——

  efficiently deliver various drugs, including therapeutic nucleic acids, into the cells is conjugating them with different transport ligands via labile or stable bonds. A convenient solid-phase approach for the synthesis of 5′-conjugates of oligonucleotides with biodegradable pH-sensitive hydrazone covalent bonds is proposed in this article. The approach relies on introducing a hydrazide of the ligand

  有效地将包括治疗性核酸在内的各种药物输送到细胞中的一种方法是，通过不稳定或稳定的键将它们与不同的转运配体结合。本文提出了一种方便的固相方法，用于合成具有可生物降解的pH敏感共价键的寡核苷酸5'-共轭物。该方法依赖于在水/有机介质下将配体的酰肼引入到完全保护的，在5'-末端具有醛功能的与载体结合的寡核苷酸。我们通过合成修饰的siRNA和导入线粒体的非编码RNAs的5'-亲脂性（例如胆固醇和α-生育酚）共轭物（反复制RNA和针对Mito-CRISPR / system的指导RNAs）证明了这种方法的原理）。O-甲基核糖和其他）具有不同性质的配体。
• Schwarz, Gerd; Alberts, Heinrich; Kricheldorf, Hans R., Liebigs Annalen der Chemie, 1981, # 7, p. 1257 - 1270
  作者：Schwarz, Gerd、Alberts, Heinrich、Kricheldorf, Hans R.

  DOI：——

  日期：——
• Herstellung von N-Silyloxycarbonyl-aminosäure-Derivaten
  作者：Hans R. KRICHELDORF

  DOI：10.1055/s-1970-21602

  日期：——
• Ruehlmann, Journal fuer Praktische Chemie (Leipzig), 1959, vol. <4>9, p. 86,89,90,315,318
  作者：Ruehlmann

  DOI：——

  日期：——
• Studies Directed at the Use of a Parallel Synthesis Matrix to Increase Throughput in an in Vivo Assay
  作者：Andrea Leone-Bay、John Freeman、Doris O'Toole、Connie Rosado-Gray、Sirpa Salo-Kostmayer、Monica Tai、Frank Mercogliano、Robert A. Baughman

  DOI：10.1021/jm990416r

  日期：2000.9.1

  Heparin is the anticoagulant of choice for hospitalized patients, but it is dosed only by injection because it is not absorbed following oral administration. We have discovered and prepared compounds (delivery agents) that facilitate the gastrointestinal absorption of heparin in rats, monkeys, and humans when given orally. We are currently developing a parallel synthesis approach to increase our delivery agent screening throughput in vivo. This approach has been used to produce micromolar quantities of compounds for testing in rats in a 5 x 5 parallel synthesis array. Using an amine benzoylation reaction sequence, 10 mixtures were prepared. These mixtures contained equal weight quantities of five N-substituted, non-alpha, amino acid delivery agents. Each of these mixtures was orally administered to rats in combination with heparin, and plasma clotting times (APTT) were measured to determine activity. Deconvolution of the data accurately identified the most active individual components. Independent synthesis of these compounds verified their activity. This parallel synthesis approach is an effective tool for the screening of oral heparin delivery agents and has increased screening throughput significantly.